Latest Industry Insights

To learn more about AI laboratory notebooks (AILNs) and how ELaiN is helping scientists move from note-taking to discovery, Technology Networks spoke with Dr. Rob Brown, global vice president and head of scientific office at Sapio Sciences.

Industry leaders outline how advances in MS, affinity platforms, sample preparation, AI-driven analysis, and data standardization are transforming proteomics. These innovations are enabling deeper and clinically relevant protein measurement.

Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling faster, targeted treatment.

In this interview, Dr. Steve Ward-Smith explores the analytical challenges and opportunities shaping the development of nasal spray therapeutics.

Discover how new developments in cryo-electron microscopy are set to transform biological imaging by supporting more targeted analysis.

PRT120 is an investigational peanut oral immunotherapy designed to induce immune remission rather than temporary desensitization. Clinical studies show large, sustained reductions in peanut-specific IgE and shifts in T cell responses.

An exploratory study shows that combining short-term topical microdosing with gene-expression profiling can detect early drug activity in atopic dermatitis. Researchers observed disease-relevant molecular changes within 24 hours.

In this interview, Mark Fish discusses innovations that are helping labs overcome current barriers and making automation more accessible.

Technology Networks recently spoke with Dr. Birgit Schilling, a professor at the Buck Institute for Research on Aging, to learn how she is using proteomics to decode the molecular signatures of aging and what they reveal about human health.

In this interview, Claudio Panzarella and Angelo Raggioli discuss advances in ReiThera's viral vector platforms and the advantages they offer.